McKesson and TrakCel Launch Innovative Collaboration to Support Commercialization of Cell and Gene Therapies
Summary
IRVING, Texas & CARDIFF, Wales--(BUSINESS WIRE)--McKesson, a leading provider of third-party logistic (3PL) services, patient access support and specialty pharmacy solutions, and TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, today announce a collaboration to support cell and gene therapy late-stage developers. The collaboration will integrate both companies’ supply chain tracking and patient access services to enable a more efficient path for the industry to develop the next-generation of commercial therapies. Combining TrakCel’s data tracking and personalized medicine orchestration software system with McKesson’s existing high-touch patient platform, as well as both companies’ expertise and support, will provide an end-to-end solution for the cell and gene therapy industry to manage the entire therapeutic supply chain. This includes automatic scheduling of product-specific workflows across multiple supply chain partners and care team members, and validated chain-of-identity tracking to guarantee correct drug product delivery. McKesson has been named a “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly.
Classifications
AskAI Classifications
LabelsLinked Companies
